|
Investment Presentation
|
19 May 2023 at 12:50pm
|
|
Change of Director's Interest Notice
|
10 May 2023 at 4:20pm
|
|
Change of Director's Interest Notice
|
10 May 2023 at 4:20pm
|
|
Change of Director's Interest Notice
|
10 May 2023 at 4:15pm
|
|
Change of Director's Interest Notice
|
10 May 2023 at 4:15pm
|
|
Change in substantial holding
|
10 May 2023 at 12:50pm
|
|
Application for quotation of securities - EYE
|
5 May 2023 at 11:20am
|
|
Cleansing Notice
|
5 May 2023 at 11:20am
|
|
iTrack Advance First Surgeries and Sales in USA
|
1 May 2023 at 10:20am
|
|
Results of General Meeting
|
28 April 2023 at 1:15pm
|
|
FDA Clears iTrack Advance for US Launch
|
31 March 2023 at 9:55am
|
|
Notice Of General Meeting
|
28 March 2023 at 12:10pm
|
|
Cleansing notice
|
8 March 2023 at 11:40am
|
|
Application for quotation of securities - EYE
|
8 March 2023 at 11:25am
|
|
Proposed issue of securities - EYE
|
2 March 2023 at 9:25am
|
|
Reinstatement to Quotation
|
2 March 2023 at 9:25am
|
|
Investor Presentation
|
2 March 2023 at 9:25am
|
|
Nova Eye Completes Placement
|
2 March 2023 at 9:25am
|
|
Suspension from Official Quotation
|
1 March 2023 at 8:30am
|
|
Half Year Accounts
|
1 March 2023 at 8:30am
|
|
Trading Halt
|
27 February 2023 at 9:30am
|
|
Glaucoma Surgical Devices Sales Update
|
30 January 2023 at 7:40pm
|
|
Notification of cessation of securities - EYE
|
27 January 2023 at 1:20pm
|
|
Additional Clinical Application for 2RT
|
25 January 2023 at 8:40am
|
|
Status of MArket Clearance for iTrack Advance in the USA
|
12 December 2022 at 8:55am
|
|
Application for quotation of securities - EYE
|
25 November 2022 at 11:40am
|
|
AGM Voting Results
|
17 November 2022 at 3:20pm
|
|
AGM presentation 2022
|
17 November 2022 at 11:55am
|
|
Clarification Glaucoma Surgical Devices Sales Update
|
16 November 2022 at 10:10am
|
|
Glaucoma Surgical Devices Sales Update
|
16 November 2022 at 9:10am
|
|
AlphRet Completes Initial Recruitment of Investigator Sites
|
24 October 2022 at 10:20am
|
|
Notice of Annual General Meeting 2022
|
14 October 2022 at 11:45am
|
|
Notification regarding unquoted securities - EYE
|
16 September 2022 at 3:05pm
|
|
Application for quotation of securities - EYE
|
16 September 2022 at 2:45pm
|
|
Notification regarding unquoted securities - EYE
|
16 September 2022 at 2:40pm
|
|
2RT Presentation Professor Robyn H Guymer
|
15 September 2022 at 8:55am
|
|
Appendix 3Y T Spurling
|
14 September 2022 at 4:30pm
|
|
AGM Date and Directors Nominations
|
14 September 2022 at 11:00am
|
|
2RT Webinar Professor Robyn H Guymer MMBBS, PHD
|
9 September 2022 at 3:45pm
|
|
Notification of cessation of securities - EYE
|
6 September 2022 at 10:00am
|
|
Notification of cessation of securities - EYE
|
6 September 2022 at 10:00am
|
|
Appendix 4G and Corporate Governance Statement
|
26 August 2022 at 10:35am
|
|
Investor Presentation FY22
|
26 August 2022 at 10:35am
|
|
Results Announcement FY22
|
26 August 2022 at 10:35am
|
|
Appendix 4E and Annual Report FY22
|
26 August 2022 at 10:30am
|
|
Expiry of Voluntary Escrow Conditions
|
12 August 2022 at 10:30am
|
|
Glaucoma Sales update
|
8 July 2022 at 9:55am
|
|
iTrack Advance Commercial Roll-Out Commenced
|
8 June 2022 at 9:25am
|
|
Notification regarding unquoted securities - EYE
|
25 May 2022 at 10:25am
|
|
Application for quotation of securities - EYE
|
17 May 2022 at 4:45pm
|
